Back to News
Market Impact: 0.15
MUV Doubles Down on Life Sciences, Completes Sale of Its Meetings & Events Division to miMeetings
Source: PR Newswire
Healthcare & BiotechTransportation & LogisticsCompany Fundamentals
After 25 years serving corporate, event and clinical-research transportation needs, MUV says it is becoming a single-focus company centered on moving people who bring new therapies to patients. Clinical-trial patient transportation will be its core, supported by a network of certified patient drivers in more than 40 [the article text is truncated].
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales
- Softbank’s $5.4 bln takeover of ABB robotics unit blocked by China- FT
- Snap shares fall over 10% on third-quarter earnings miss
- Host Hotels & Resorts CEO on 3Q Quarterly Results
- Up 37% since March - this AI-picked IT services stock keeps climbing